← FDA Drug Approvals (Drugs@FDA)

DUREZOL

NDA · New Drug Application · Sponsor: SANDOZ · Approved 2008-06-23

Drug application

FDA Application #

NDA022212

Application type

New Drug Application

Brand name

DUREZOL

Generic name

DIFLUPREDNATE OPHTHALMIC

Active ingredients

DIFLUPREDNATE

Dosage form

EMULSION

Route

OPHTHALMIC

Marketing status

Prescription

Sponsor

SANDOZ

Manufacturer

Sandoz Inc

First approval

2008-06-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown